🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

I know you’ve all been on tenterhooks, awaiting the dramatic conclusion to “How PCP Became PJP”. Well here it is. You’ll laugh! You’ll cry! And you’ll finish reading it so much better informed about this critical debate. NEJM Journal Watch NEJM blogs.jwatch.org/hiv-id-observa…

In the aftermath of the election results, I thought of this really interesting piece from 2022, written anonymously. There's a lot here that's worth reading for us ID docs, whether we agree or not. #IDTwitter Vinay Prasad MD MPH drvinayprasad.com/p/why-no-one-w…

So grateful for the invitation to join your impressive ID division for a couple of days! Thank you! Great to reconnect with Josh Barocas, MD*, spend time on a snowy drive with @EPoeschla, and chat with many faculty and fellows. (* MGB Infectious Diseases Fellowship grad.)

Hi folks, have always loved this Allman Brothers Band song, which seems appropriate to post on this fine clear day. C'mon over to paulsaxmd.bsky.social youtu.be/JSMubgZoL58?si…

Norovirus = misery Some interesting facts worth knowing: blogs.jwatch.org/hiv-id-observa…

The communications pause for federal health agencies meant that the CDC couldn't publish MMWR last week -- first time in the publication's 60+ year history this has happened. Not happy☹️-- MMWR is a vital communication tool about infectious threats. blogs.jwatch.org/hiv-id-observa…

If someone thinks the measles outbreak and childhood death in Texas are "not unusual" or that these things "happen all the time", they are deeply misinformed. Don't be fooled. blogs.jwatch.org/hiv-id-observa…

Excited to work with Drs. Laura Waters and Magnus Gisslen again to summarize the top studies from #CROI2025. March 31st! Sign up to join us! medevents.se/events/ch2-202

Now with correct sign-up link! medevents.se/events/ch2-2025

Really Rapid Review of #CROI2025, which was a very strange conference given the current state of things. But still plenty of good content. Enjoy! blogs.jwatch.org/hiv-id-observa…

Latest post on a new antibiotic, gepotidacin, which has a novel mechanism of action, is the first new drug for uncomplicated UTIs in decades, and has a brand name that sounds a lot like a tropical bird. Plus some digressions on prog rock, for no reason. blogs.jwatch.org/hiv-id-observa…

Remember ICAAC? Bad name, weirder pronunciation ("ick-kack"), and a classic case study in conference identity crisis. A look back—and where the big ID trials land now, which is ESCMID Global. Following closely! #IDSky blogs.jwatch.org/hiv-id-observa…

The SNAP trial may finally resolve some of the longest-running debates in SAB management (cefazolin vs semi-synthetic PCN? Is PCN really active vs PSSA?). Congrats to Steven Tong Joshua Davis, and the global team who made this ambitious trial happen. blogs.jwatch.org/hiv-id-observa…

TB rule outs, Abx allergies, CMV, MSSA (of course), and more. Studies sent to an awesome ID fellow during 2 weeks of service — organized for subconscious absorption. 🧠 Link-o-Rama: Osmosis Edition blogs.jwatch.org/hiv-id-observa…

The new head of FDA’s CBER, Vinay Prasad MD MPH, is undoubtedly brilliant. He'll oversee vaccines, gene Rx, monoclonal Abs, & blood products. Let's hope he can get along well enough with others to be an effective leader -- the stakes are pretty darn high! blogs.jwatch.org/hiv-id-observa…

We love what we do. But yes, we’d also like to get paid. ID is a cognitive, consult-heavy specialty -- and often a “loss leader” in a fee-for-service world. A look at how the money actually flows (or doesn’t), Part 1. h/t ron nahass Brad Spellberg 👇 blogs.jwatch.org/hiv-id-observa…

Latest FDA actions on Covid vaccines: 1. Novavax approved: 👏 2. Narrowed indications for all vaccines: ➕/➖ 3. Called for more clinical trials:👍 Thoughts about what this might mean -- and 100% agree we need updated data to inform clinical practice. blogs.jwatch.org/hiv-id-observa…

Before the ID salary talk, a quick protest: 3 recent vaccine-related moves — all alarming. Then in Part 2 of How ID Doctors Get Paid: - Infection control - Abx stewardship - Contracts for care - Telehealth - Travel clinics (+ dog video, of course.) blogs.jwatch.org/hiv-id-observa…

In the 3rd (and final) “How ID Doctors Get Paid” series, here are three less-visible salary sources for ID physicians: • Infusion services • 340B pharmacy • Industry-sponsored clinical trials Plus--why is this topic so taboo in our field? blogs.jwatch.org/hiv-id-observa…

The head of HHS said he’d preserve ACIP. Then he fired the entire committee. Now a new panel--with mostly unclear expertise in clinical trials, vaccines, and ID--is in place. Time for high alert for changes that could seriously affect public health. blogs.jwatch.org/hiv-id-observa…